1. Harris MI, Flegal KM, Cowie CC, et. al.  Prevalence of diabetes, impaired fasting glucose and impaired glucose tolerance in US adults.  The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 21(4):518-24, 1998.
2. Gregg EW, Engelgau MM, Narayan V. Complications of diabetes in elderly people. BMJ 325:916-917, 2002.
3. King H, Aubert RE, Herman WH.  Global burden of diabetes 1995-2025: Prevalence, numerical estimates, and projections.  Diabetes Care 21:1414-31, 1998.
4. California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes.  Guidelines for Improving the Care of the Older Person with Diabetes Mellitus.  JAGS 51:S265-S280, 2003.
5. American Diabetes Association.  Clinical Practice Recommendations 2010. Diabetes Care 33(Supp1):S62-70, 2010.
6. Ibid; pages S11-61.
7. Bertoni, AG, Krop JS, Anderson GF, Brancati FL. Diabetes-related Morbidity and Mortality in a National Sample of U.S. Elders.  Diabetes Care 25:471-475, 2002.
8. Gregg EW, Yaffe K, Cauley JA, et al.  Is Diabetes Associated with Cognitive Impairment and Cognitive Decline Among Older Women?  Study of Osteoporotic Fractures Research Group.  Arch Intern Med 160:174-180, 2000.
9. Feil D, Unutzer J. Cognitive impairment, chronic medical illness, and risk of mortality in an elderly cohort.  Am J Geriatr Psych 11:551-560, 2003.
10. Tinetti ME, Williams TF, Mayewski R. Fall Risk Index for Elderly Patients Based on Number of Chronic Disabilities.  Am J Med 80:429-434, 1986.
11. United Kingdom Prospective Diabetes Study Group.  Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 352:837-853, 1998.
12. Selvin E et al. The Burden and Treatment of Diabetes in Elderly Individuals in the U.S., Diabetes Care 21(11):2415-9, 2006.
13. Olson D, Norris S. Diabetes in older adults:  Overview of the AGS guidelines for the treatment of diabetes mellitus in geriatric populations.  Geriatrics 59:18-24, 2004.
14. Sakharova O, Inzucchi S. Treatment of diabetes in the elderly:  Addressing its complexities in this high-risk group.  Postgraduate medicine 119:19-29, 2005.
15. Riddle MC and Drucker DJ.  Emerging Therapies Mimicking the Effects of Amylin and Glucagon-Like Peptide 1.  Diabetes Care 29:535-49, 2006.
16. Bailey CJ, Turner RC. Metformin.  N Engl J Med 334:574-9, 1996.
17. Inzucchi S. Oral Anti-hyperglycemic Therapy for Type 2 Diabetes:  Scientific Review. JAMA 287:360-372, 2002.
18. Drucker D, Easley C, Kirkpatrick P.  Sitagliptin.  Nat Rev Drug Dis  6:109-110, 2007.
19. Keating G. Exenatide.  Drugs 65(12):1681-1692, 2005.
20. Victoza [package insert]. Princeton, NJ: Novo Nordisk Inc.; Jan 2010.
21. Riddle M et al. Treat to Target. Diabetes Care 26:3080-3086, 2003.
22. Rave. Advantage of Premeal Injected Insulin Glulisine Compared with Regular Human Insulin in Subjects with Type 1 Diabetes.  Diabetes Care 29(8):1812-1817, 2006.
23. David M. Nathan, John B. Buse, Mayer B. Davidson, Robert J. Heine, Rury R. Holman, Robert Sherwin, and Bernard Zinman. Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.  Diabetes Care 29:1963-1972, 2006.
24. Nateglinide. The Medical Letter. 43(1101): 27-30.
25. Kahn S, et al. for the ADOPT Study Group.  Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy.  N Engl J Med 355:2427-2443, 2006.
26. Schwartz A, et al. Health, Aging and Body Composition (Health ABC) Study, Thiazolidinedione Use and Bone Loss in Older Diabetic Adults. J Clin Endocrinol Metab 91(9):3349-3354, 2006.
27. Nissen S, Wolski K. Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes.  NEJM 356(24):2457-2471, 2007.
28. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986, 1993.
29. United Kingdom Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes.  UKDPS 38. BMJ  318:703-13, 1998.
30. Collins R, Armitage J, Parish S, Sleigh P, Peto R. Heart Protection Study Collaborative Group.  MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomized trial.  Lancet 361:2005-16, 2003.